163 related articles for article (PubMed ID: 33219265)
1. Technical validation of a new microfluidic device for enrichment of CTCs from large volumes of blood by using buffy coats to mimic diagnostic leukapheresis products.
Guglielmi R; Lai Z; Raba K; van Dalum G; Wu J; Behrens B; Bhagat AAS; Knoefel WT; Neves RPL; Stoecklein NH
Sci Rep; 2020 Nov; 10(1):20312. PubMed ID: 33219265
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting.
Fehm TN; Meier-Stiegen F; Driemel C; Jäger B; Reinhardt F; Naskou J; Franken A; Neubauer H; Neves RPL; van Dalum G; Ruckhäberle E; Niederacher D; Rox JM; Fischer JC; Stoecklein NH
Cytometry A; 2018 Dec; 93(12):1213-1219. PubMed ID: 30551262
[TBL] [Abstract][Full Text] [Related]
3. Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis.
Stoecklein NH; Fluegen G; Guglielmi R; Neves RPL; Hackert T; Birgin E; Cieslik SA; Sudarsanam M; Driemel C; van Dalum G; Franken A; Niederacher D; Neubauer H; Fehm T; Rox JM; Böhme P; Häberle L; Göring W; Esposito I; Topp SA; Coumans FAW; Weitz J; Knoefel WT; Fischer JC; Bork U; Rahbari NN
Mol Cancer; 2023 Nov; 22(1):181. PubMed ID: 37957606
[TBL] [Abstract][Full Text] [Related]
4. Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products.
Franken A; Driemel C; Behrens B; Meier-Stiegen F; Endris V; Stenzinger A; Niederacher D; Fischer JC; Stoecklein NH; Ruckhaeberle E; Fehm T; Neubauer H
Clin Chem; 2019 Apr; 65(4):549-558. PubMed ID: 30737205
[TBL] [Abstract][Full Text] [Related]
5. Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap).
Andree KC; Mentink A; Zeune LL; Terstappen LWMM; Stoecklein NH; Neves RP; Driemel C; Lampignano R; Yang L; Neubauer H; Fehm T; Fischer JC; Rossi E; Manicone M; Basso U; Marson P; Zamarchi R; Loriot Y; Lapierre V; Faugeroux V; Oulhen M; Farace F; Fowler G; Sousa Fontes M; Ebbs B; Lambros M; Crespo M; Flohr P; de Bono JS
Int J Cancer; 2018 Nov; 143(10):2584-2591. PubMed ID: 30006930
[TBL] [Abstract][Full Text] [Related]
6. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
[TBL] [Abstract][Full Text] [Related]
7. Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival.
Tamminga M; Andree KC; van den Bos H; Hiltermann TJN; Mentink A; Spierings DCJ; Lansdorp P; Timens W; Schuuring E; Terstappen LWMM; Groen HJM
Br J Cancer; 2022 Feb; 126(3):409-418. PubMed ID: 34848855
[TBL] [Abstract][Full Text] [Related]
8. Improved enrichment of circulating tumor cells from diagnostic leukapheresis product.
Stevens M; Mentink A; Nanou A; Coumans FAW; Isebia KT; Kraan J; Hamberg P; Martens JWM; Terstappen LWMM
Cytometry A; 2023 Nov; 103(11):881-888. PubMed ID: 37461156
[TBL] [Abstract][Full Text] [Related]
9. Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch
Tamminga M; Andree KC; Hiltermann TJN; Jayat M; Schuuring E; van den Bos H; Spierings DCJ; Lansdorp PM; Timens W; Terstappen LWMM; Groen HJM
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32272669
[TBL] [Abstract][Full Text] [Related]
10. MagPure chip: an immunomagnetic-based microfluidic device for high purification of circulating tumor cells from liquid biopsies.
Descamps L; Garcia J; Barthelemy D; Laurenceau E; Payen L; Le Roy D; Deman AL
Lab Chip; 2022 Oct; 22(21):4151-4166. PubMed ID: 36148526
[TBL] [Abstract][Full Text] [Related]
11. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.
Stoecklein NH; Fischer JC; Niederacher D; Terstappen LW
Expert Rev Mol Diagn; 2016; 16(2):147-64. PubMed ID: 26587751
[TBL] [Abstract][Full Text] [Related]
12. Flow-based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product.
Stevens M; Mentink A; Coumans FAW; Dathathri E; Isebia KT; Kraan J; de Wit R; Martens JWM; Terstappen LWMM
Mol Oncol; 2023 Dec; ():. PubMed ID: 38073130
[TBL] [Abstract][Full Text] [Related]
13. Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumor cells.
Mishra A; Dubash TD; Edd JF; Jewett MK; Garre SG; Karabacak NM; Rabe DC; Mutlu BR; Walsh JR; Kapur R; Stott SL; Maheswaran S; Haber DA; Toner M
Proc Natl Acad Sci U S A; 2020 Jul; 117(29):16839-16847. PubMed ID: 32641515
[TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
[TBL] [Abstract][Full Text] [Related]
15. An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells.
Warkiani ME; Khoo BL; Tan DS; Bhagat AA; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT
Analyst; 2014 Jul; 139(13):3245-55. PubMed ID: 24840240
[TBL] [Abstract][Full Text] [Related]
16. Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients.
Tamminga M; Oomens L; Hiltermann TJN; Andree KC; Tibbe A; Broekmaat J; Schuuring E; Terstappen LWMM; Groen HJM
Transl Lung Cancer Res; 2020 Aug; 9(4):1093-1100. PubMed ID: 32953488
[TBL] [Abstract][Full Text] [Related]
17. Inertial focusing of circulating tumor cells in whole blood at high flow rates using the microfluidic CTCKey™ device for CTC enrichment.
Smith KJ; Jana JA; Kaehr A; Purcell E; Opdycke T; Paoletti C; Cooling L; Thamm DH; Hayes DF; Nagrath S
Lab Chip; 2021 Sep; 21(18):3559-3572. PubMed ID: 34320046
[TBL] [Abstract][Full Text] [Related]
18. Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients.
Ribeiro-Samy S; Oliveira MI; Pereira-Veiga T; Muinelo-Romay L; Carvalho S; Gaspar J; Freitas PP; López-López R; Costa C; Diéguez L
Sci Rep; 2019 May; 9(1):8032. PubMed ID: 31142796
[TBL] [Abstract][Full Text] [Related]
19. Analytical Validation of a Spiral Microfluidic Chip with Hydrofoil-Shaped Pillars for the Enrichment of Circulating Tumor Cells.
Sen-Dogan B; Demir MA; Sahin B; Yildirim E; Karayalcin G; Sahin S; Mutlu E; Toral TB; Ozgur E; Zorlu O; Kulah H
Biosensors (Basel); 2023 Oct; 13(10):. PubMed ID: 37887131
[TBL] [Abstract][Full Text] [Related]
20. Microfluidic-Based Technologies for CTC Isolation: A Review of 10 Years of Intense Efforts towards Liquid Biopsy.
Descamps L; Le Roy D; Deman AL
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
